Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amicus Therapeutics (FOLD) Revenue: 2009-2024

Historic Revenue for Amicus Therapeutics (FOLD) over the last 16 years, with Dec 2024 value amounting to $528.3 million.

  • Amicus Therapeutics' Revenue rose 19.46% to $169.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $598.7 million, marking a year-over-year increase of 21.28%. This contributed to the annual value of $528.3 million for FY2024, which is 32.29% up from last year.
  • Latest data reveals that Amicus Therapeutics reported Revenue of $528.3 million as of FY2024, which was up 32.29% from $399.4 million recorded in FY2023.
  • In the past 5 years, Amicus Therapeutics' Revenue ranged from a high of $528.3 million in FY2024 and a low of $260.9 million during FY2020.
  • Moreover, its 3-year median value for Revenue was $399.4 million (2023), whereas its average is $419.0 million.
  • Data for Amicus Therapeutics' Revenue shows a peak YoY soared of 43.16% (in 2020) over the last 5 years.
  • Amicus Therapeutics' Revenue (Yearly) stood at $260.9 million in 2020, then rose by 17.11% to $305.5 million in 2021, then rose by 7.76% to $329.2 million in 2022, then increased by 21.30% to $399.4 million in 2023, then surged by 32.29% to $528.3 million in 2024.